Erste Asset Management Gmb H Kezar Life Sciences, Inc. Transaction History

Erste Asset Management Gmb H

  • $8.15 Trillion
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 26, 2024
SELL
$1.08 - $2.54 $33,480 - $78,740
-31,000 Closed
0 $0
Q3 2022

Nov 26, 2024
BUY
$7.99 - $10.75 $247,690 - $333,250
31,000 New
31,000 $267 Million
Q2 2022

Nov 26, 2024
BUY
$4.58 - $17.13 $141,980 - $531,030
31,000 New
31,000 $246 Million
Q1 2022

Nov 22, 2024
BUY
$12.3 - $18.33 $381,300 - $568,230
31,000 New
31,000 $524 Million

Others Institutions Holding KZR

# of Institutions
4
Shares Held
1.54M
Call Options Held
0
Put Options Held
0
View Full List

About Kezar Life Sciences, Inc.

KZR Quotes by TradingView
  • Ticker KZR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,369,504
  • Market Cap $414M
  • Description
  • Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...
More about KZR
Track This Portfolio

Track Erste Asset Management Gmb H Portfolio

Follow Erste Asset Management Gmb H and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Erste Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Erste Asset Management Gmb H with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email